Catalyst Wire Dossier Catalyst Wire Dossier

GZR4

· Gan and Lee Pharmaceuticals, USA
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for GZR4, covering 2024-08-12 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM) [Phase 3]

See pricing